Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy.
Saved in:
| Title: | Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy. |
|---|---|
| Authors: | Särchen V; Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt am Main, Germany., Shanmugalingam S; Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt am Main, Germany., Kehr S; Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt am Main, Germany., Reindl LM; Children's Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany.; Experimental Immunology, Goethe-University Frankfurt, Frankfurt am Main, Germany., Greze V; Children's Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany.; Experimental Immunology, Goethe-University Frankfurt, Frankfurt am Main, Germany., Wiedemann S; Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt am Main, Germany., Boedicker C; Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt am Main, Germany., Jacob M; Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt am Main, Germany., Bankov K; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany., Becker N; Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany.; University Cancer Center Frankfurt (UCT), University Hospital Frankfurt, Goethe-University Frankfurt, Frankfurt am Main, Germany., Wehner S; Children's Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany., Theilen TM; Department of Pediatric Surgery and Pediatric Urology, University Hospital Frankfurt, Goethe-University Frankfurt, Frankfurt am Main, Germany., Gretser S; Department of Pediatric and Perinatal Pathology, Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany., Gradhand E; Department of Pediatric and Perinatal Pathology, Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany., Kummerow C; Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Saarland, Germany., Ullrich E; Children's Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany.; Experimental Immunology, Goethe-University Frankfurt, Frankfurt am Main, Germany.; University Cancer Center Frankfurt (UCT), University Hospital Frankfurt, Goethe-University Frankfurt, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Goethe-University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz, Frankfurt am Main, Germany., Vogler M; Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Frankfurt am Main, Germany. m.vogler@kinderkrebsstiftung-frankfurt.de.; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz, Frankfurt am Main, Germany. m.vogler@kinderkrebsstiftung-frankfurt.de. |
| Source: | Cell death discovery [Cell Death Discov] 2022 Jan 10; Vol. 8 (1), pp. 11. Date of Electronic Publication: 2022 Jan 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
